Filing Flows

Filing Flows › Pediatrix Medical Group (MD) › Q3 2025

Pediatrix Medical Group (MD) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 3, 2025

Pediatrix Medical Group (MD) reported revenue of $493M for the third quarter 2025 (Q3 2025), -4% from a year earlier and +5% from the quarter before. Operating margin was 13.8%, net earnings $71.7M (14.5% of revenue).

Revenue$493M
Year over year-4%
Quarter over quarter+5%
Operating margin13.8%
Net earnings$71.7M

Pediatrix Medical Group, Q3 2025: revenue $493M (-4% year over year), operating margin 13.8%, net earnings $71.7M, operating cash flow $137M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$493M+5%-4%
Operating profit$68.1M+14%+101%
Net earnings$71.7M+83%+269%
Operating cash flow$137M+0.1%+49%
Free cash flow$132M-0.5%+54%

What changed

Revenue was $492.9M in Q3 2025, down 4% year over year and up 5% from the previous quarter. Health Care Patient Service was the largest line at 86% of revenue. Health Care Patient Service lost $16.5M year over year (down 4%), 90% of the total change.

Operating profit was $68.1M, a 13.8% margin (up 7.2 points year over year). Total costs fell 11% while revenue fell 4%. Net earnings were $71.7M, up 269% year over year. The effective tax rate was 18.3%. Non-operating items added $19.7M, 22% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $137.3M (up 49% year over year), 191% of net earnings. Non-cash charges added back $5.6M of depreciation and amortization and $5.2M of share-based compensation. Working capital and other items added $54.9M. Capital expenditures of $5.3M left free cash flow of $131.9M.

Questions

What was Pediatrix Medical Group's revenue in the third quarter 2025?

Pediatrix Medical Group (MD) reported revenue of $493M for the third quarter 2025 (Q3 2025), -4% from a year earlier and +5% from the quarter before.

Was Pediatrix Medical Group profitable in the third quarter 2025?

Operating profit was $68.1M (13.8% of revenue) and net earnings $71.7M.

Open the interactive Sankey →

Source: Pediatrix Medical Group 10-Q on SEC EDGAR.